180 Participants Needed

Pain Medication for Knee Osteoarthritis

(PREDICT Trial)

GW
NS
Overseen ByNarina Simonian, BS, CCRC
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib, or placebo. Participants will have an Xray, knee MRI, brain MRI, blood draws, pain sensitivity testing, and asked to fill out questionnaires. The purpose of this study is to try to predict which participants will respond to the treatment.

Will I have to stop taking my current medications?

The trial requires that you stay on a stable dose of any current therapies you are using, like TENs units or glucosamine. However, if you are using high-dose opioids, certain antidepressants, or cannabinoids for knee pain, you may need to stop or adjust those medications to participate.

Is duloxetine safe for treating knee osteoarthritis pain?

Research shows that duloxetine has been studied for safety in treating knee osteoarthritis pain, and it is generally considered safe for use in humans, though older patients may have a higher risk of side effects due to age-related changes.12345

How is the drug combination of Celecoxib and Duloxetine unique for treating knee osteoarthritis?

The combination of Celecoxib and Duloxetine is unique because Duloxetine is a centrally acting analgesic that not only helps with knee osteoarthritis pain but also addresses depression, which can be common in chronic pain conditions. This dual action can be particularly beneficial for patients who experience both pain and depressive symptoms.15678

What data supports the effectiveness of the drug duloxetine for knee osteoarthritis pain?

Research shows that duloxetine can significantly reduce pain and improve quality of life for people with knee osteoarthritis, especially when used alongside other pain medications like NSAIDs (nonsteroidal anti-inflammatory drugs).25789

Who Is on the Research Team?

Thomas J. Schnitzer, MD, PhD ...

Thomas Schnitzer

Principal Investigator

Northwestern University

Are You a Good Fit for This Trial?

This trial is for individuals with knee pain from osteoarthritis. Participants will undergo various tests including X-rays, MRIs, and questionnaires at Northwestern University over approximately 20 weeks. Key requirements include having knee osteoarthritis and being able to complete the study activities.

Inclusion Criteria

I am in stable health overall.
I can attend all required clinic visits.
I understand the study's purpose, procedures, benefits, and risks and agree to participate.
See 6 more

Exclusion Criteria

Any medical condition in that in the investigator's judgement may prevent the individual from completing the study or put the individual at undue risk
In the judgement of the investigator, unable or unwilling to follow protocol instructions
I haven't had injections in my knee with hyaluronic acid or steroids recently.
See 16 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomly assigned to receive duloxetine, celecoxib, or placebo for two treatment periods

16 weeks
Regular visits for assessments and monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Celecoxib
  • Duloxetine
  • Placebo
Trial Overview The study compares the effectiveness of two medications, Celecoxib and Duloxetine, against a placebo in managing knee osteoarthritis pain. It aims to predict who will benefit from these treatments based on brain-based and clinical assessments.
How Is the Trial Designed?
3Treatment groups
Active Control
Placebo Group
Group I: DuloxetineActive Control1 Intervention
Group II: CelecoxibActive Control1 Intervention
Group III: PlaceboPlacebo Group1 Intervention

Celecoxib is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Celebrex for:
🇪🇺
Approved in European Union as Celebrex for:
🇨🇦
Approved in Canada as Celebrex for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+

Brigham and Women's Hospital

Collaborator

Trials
1,694
Recruited
14,790,000+

Published Research Related to This Trial

Duloxetine significantly reduces knee osteoarthritis pain and improves physical function, as shown in a systematic review of 6 studies with 2059 patients, indicating its efficacy as a treatment option.
Despite its effectiveness, duloxetine did not show a significant difference in serious adverse events compared to placebo, suggesting it may have a similar safety profile, but further well-controlled studies are needed.
An Updated Systematic Review and Meta-analysis of Duloxetine for Knee Osteoarthritis Pain.Chen, B., Duan, J., Wen, S., et al.[2023]
Adding duloxetine to the usual care for knee osteoarthritis (OA) patients with moderate pain is cost-effective, providing significant health benefits (31 additional quality-adjusted life years per 1,000 subjects) at a reasonable cost of $39,300 per quality-adjusted life year.
Implementing a depression screening strategy before prescribing duloxetine also proves beneficial, yielding 17 additional quality-adjusted life years per 1,000 subjects at a cost of $17,000 per quality-adjusted life year, making it a viable option for improving patient outcomes.
Does Screening for Depressive Symptoms Help Optimize Duloxetine Use in Knee Osteoarthritis Patients With Moderate Pain? A Cost-Effectiveness Analysis.Lenhard, NK., Sullivan, JK., Ross, EL., et al.[2023]
In a study of 353 Japanese patients with knee osteoarthritis, duloxetine significantly reduced pain and improved health-related quality of life compared to placebo over a 14-week period, regardless of prior NSAID use patterns.
Duloxetine consistently led to greater reductions in pain severity and improvements in physical function across all subgroups of prior NSAID users, indicating its efficacy as a treatment option for knee OA pain.
Efficacy of duloxetine by prior NSAID use in the treatment of chronic osteoarthritis knee pain: A post hoc subgroup analysis of a randomized, placebo-controlled, phase 3 study in Japan.Enomoto, H., Fujikoshi, S., Tsuji, T., et al.[2019]

Citations

An Updated Systematic Review and Meta-analysis of Duloxetine for Knee Osteoarthritis Pain. [2023]
Does Screening for Depressive Symptoms Help Optimize Duloxetine Use in Knee Osteoarthritis Patients With Moderate Pain? A Cost-Effectiveness Analysis. [2023]
Efficacy of duloxetine by prior NSAID use in the treatment of chronic osteoarthritis knee pain: A post hoc subgroup analysis of a randomized, placebo-controlled, phase 3 study in Japan. [2019]
Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial. [2022]
Efficacy of duloxetine for multisite pain in patients with knee pain due to osteoarthritis: An exploratory post hoc analysis of a Japanese phase 3 randomized study. [2021]
Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials. [2021]
A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis. [2022]
A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed? [2022]
Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security